Viewing StudyNCT06410040



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06410040
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-10
First Post: 2024-05-05

Brief Title: A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK NSCLC Patients With Brain or Meningeal Metastasis
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization: Sichuan Cancer Hospital and Research Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-20
Start Date Type: ACTUAL
Primary Completion Date: 2024-03-31
Primary Completion Date Type: ACTUAL
Completion Date: 2024-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-05
First Submit QC Date: May 8 2024
Study First Post Date: 2024-05-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-08
Last Update Post Date: 2024-05-10
Last Update Post Date Type: ACTUAL